Bolt Biotherapeutics Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Stage FCFS Q1 2026 Earnings DoubleDigit EPS Beat Drives Modest Share Gains PAGP Q1 2026 Earnings Massive EPS Surprise Highlights Resilient Midstream Operations LMFA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Company Posts Zero Revenue MSGS Q1 2026 Earnings Big EPS Miss as Seasonality and Costs Weigh on Results ROAD Q1 2026 Earnings Strong EPS Beat Drives Stock Higher